This research endeavors to elucidate the therapeutic efficacy and safety profile of IPCGOR paired with IL-2 in the management of advanced NSCLC by undertaking a comprehensive clinical retrospective cohort study with a substantial sample size. The gene discussed is IL2; the disease is non-small cell lung carcinoma.